📰 Abbott Navitor News
Abbott Navitor News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abbott Navitor. Real-time updates on events, politics, business and more.
April 6, 2023
These companies have consistently delivered revenue and EPS gains.
February 28, 2023
Abbott (NYSE:ABT) announced today that studies support its next-generation Navitor TAVI system and its Amplatzer Amulet device.
January 20, 2023
Abbott's new Navitor device features advancements to improve patient care, including reducing or eliminating risk of blood leakage around valve implant
January 17, 2023
Abbott (NYSE:ABT) announced today that it received FDA approval for its latest-generation transcatheter aortic valve implant (TAVI) system.
May 17, 2021
May 17, 2021 11:35am The Navitor artificial heart valve is implanted using Abbott’s CE-marked FlexNav delivery device and reduces the blood leaks that often occur after replacement. (Abbott) After Boston Scientific retired its entire line of Lotus Edge replacement heart valves late last year amid a flurry of issues with its delivery system, Abbott has stepped up to fill in the gap in the transcatheter aortic valve replacement market. Abbott’s Navitor TAVR system has received a CE ma...